PofoliaShared via Pofolia

Nutrients· 2026Q1· Review

The Circadian Diet in Age-Related Neurodegeneration: Nutrient Timing, Sleep, and Mitochondrial Mechanisms

Cristina Manuela Drăgoi, Alina Nicolae, Ion-Bogdan Dumitrescu

Short summary

Restoring circadian alignment via diet shows mechanistic plausibility for neuroprotection in Alzheimer's and Parkinson's, but clinical evidence is lacking.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Circadian rhythms and sleep disturbances are linked to neurodegenerative disorders like Alzheimer's and Parkinson's.
  • Meal timing and dietary composition signal to peripheral clocks, influencing NAD+, sirtuins, and AMPK, which regulate mitochondrial metabolism.
  • Specific dietary components like NAD+ precursors, omega-3s, and polyphenols show mechanistic promise.
  • Despite experimental evidence, metabolic improvements have not yet led to demonstrated neuroprotection in clinical settings.
  • Future trials need to incorporate circadian-phase assessment, controlled energy intake, and clinically meaningful neurological outcomes.

AI-generated from the title and abstract; the full text is not read.

Abstract

Circadian rhythms coordinate sleep–wake regulation, endocrine secretion, nutrient handling and cellular energy metabolism. Circadian and sleep disturbances are associated with metabolic and cardiovascular morbidity and with neurodegenerative disorders, particularly Alzheimer’s disease (AD) and Parkinson’s disease (PD), although whether restoring circadian alignment modifies neurodegeneration remains uncertain. This narrative review examines chrononutrition within the broader context of sleep regulation, physical activity and circadian care, distinguishing evidence from cellular and animal models, observational studies and clinical trials. Meal timing and dietary composition act as signals to peripheral clocks, while NAD+, sirtuins and AMP-activated protein kinase link nutrient availability with clock regulation and mitochondrial metabolism. We appraise time-restricted eating, protein distribution, NAD+ precursors, tryptophan- and melatonin-containing foods, magnesium, omega-3 fatty acids, polyphenols and fermentable fiber. Experimental findings provide mechanistic plausibility, but metabolic improvements and target engagement have not translated into demonstrated neuroprotection. Clinical application must account for levodopa–protein interactions, undernutrition, frailty and sarcopenia. Adequately powered trials with circadian-phase assessment, controlled energy intake and clinically meaningful neurological outcomes are required before a “circadian diet” can be established as a disease-modifying intervention.

The authors' abstract, as published at the source. Nutrients, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Endocrine and Autonomic Systems

Endocrine and Autonomic SystemsNeuroscience